Ensurose 10 Tablet contains Rosuvastatin 10 mg, a lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production in the liver and increased clearance of LDL from the bloodstream. Ensurose 10 is prescribed as an adjunct to diet and lifestyle modifications, including exercise and weight control, to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and the need for revascularization procedures in patients with established coronary heart disease or those at high risk. The tablet is administered orally, typically once daily, with or without food. Dosage adjustments may be necessary based on therapeutic response and patient tolerance. Common adverse effects include headache, myalgia, and gastrointestinal disturbances. Periodic monitoring of lipid profiles, liver function tests, and creatine kinase levels is recommended to ensure safety and efficacy during treatment with Ensurose 10 Tablet.